78 related articles for article (PubMed ID: 24793055)
21. An orally available small molecule BCL6 inhibitor effectively suppresses diffuse large B cell lymphoma cells growth in vitro and in vivo.
Xing Y; Guo W; Wu M; Xie J; Huang D; Hu P; Zhou M; Zhang L; Zhang Q; Wang P; Wang X; Wang G; Wu H; Zhou C; Chen Y; Liu M; Yi Z; Sun Z
Cancer Lett; 2022 Mar; 529():100-111. PubMed ID: 34990752
[TBL] [Abstract][Full Text] [Related]
22. The POZ/BTB protein NAC1 interacts with two different histone deacetylases in neuronal-like cultures.
Korutla L; Wang PJ; Mackler SA
J Neurochem; 2005 Aug; 94(3):786-93. PubMed ID: 16033423
[TBL] [Abstract][Full Text] [Related]
23. Identification of Thiourea-Based Inhibitors of the B-Cell Lymphoma 6 BTB Domain via NMR-Based Fragment Screening and Computer-Aided Drug Design.
Cheng H; Linhares BM; Yu W; Cardenas MG; Ai Y; Jiang W; Winkler A; Cohen S; Melnick A; MacKerell A; Cierpicki T; Xue F
J Med Chem; 2018 Sep; 61(17):7573-7588. PubMed ID: 29969259
[TBL] [Abstract][Full Text] [Related]
24. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
Hodgson MC; Astapova I; Hollenberg AN; Balk SP
Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755
[TBL] [Abstract][Full Text] [Related]
25. The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivo.
Dhordain P; Albagli O; Ansieau S; Koken MH; Deweindt C; Quief S; Lantoine D; Leutz A; Kerckaert JP; Leprince D
Oncogene; 1995 Dec; 11(12):2689-97. PubMed ID: 8545127
[TBL] [Abstract][Full Text] [Related]
26. The NCoR Co-repressor Interacts with the Kaiso Transcription Factor through a Mechanism Different from That of BCL6 Interaction.
Balagurov KI; Georgiev PG; Bonchuk AN
Dokl Biochem Biophys; 2022 Dec; 507(1):326-329. PubMed ID: 36786995
[TBL] [Abstract][Full Text] [Related]
27. Interaction of silencing mediator for retinoid and thyroid receptors with steroid and xenobiotic receptor on multidrug resistance 1 promoter.
Hirooka-Masui K; Lesmana R; Iwasaki T; Xu M; Hayasaka K; Haraguchi M; Takeshita A; Shimokawa N; Yamamoto K; Koibuchi N
Life Sci; 2013 May; 92(17-19):911-5. PubMed ID: 23562850
[TBL] [Abstract][Full Text] [Related]
28. The BTB/POZ domain of the regulatory proteins Bric à brac 1 (BAB1) and Bric à brac 2 (BAB2) interacts with the novel Drosophila TAF(II) factor BIP2/dTAF(II)155.
Pointud JC; Larsson J; Dastugue B; Couderc JL
Dev Biol; 2001 Sep; 237(2):368-80. PubMed ID: 11543621
[TBL] [Abstract][Full Text] [Related]
29. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
Phan RT; Dalla-Favera R
Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
[TBL] [Abstract][Full Text] [Related]
30. Evolution of NCoR-1 and NCoR-2 corepressor alternative mRNA splicing in placental mammals.
Privalsky ML; Goodson ML
BMC Res Notes; 2019 Jun; 12(1):343. PubMed ID: 31208445
[TBL] [Abstract][Full Text] [Related]
31. Discovery of high-affinity BCL6-binding peptide and its structure-activity relationship.
Sakamoto K; Sogabe S; Kamada Y; Sakai N; Asano K; Yoshimatsu M; Ida K; Imaeda Y; Sakamoto JI
Biochem Biophys Res Commun; 2017 Jan; 482(2):310-316. PubMed ID: 27856253
[TBL] [Abstract][Full Text] [Related]
32. Kaiso is a key regulator of spleen germinal center formation by repressing Bcl6 expression in splenocytes.
Koh DI; Yoon JH; Kim MK; An H; Kim MY; Hur MW
Biochem Biophys Res Commun; 2013 Dec; 442(3-4):177-82. PubMed ID: 24269670
[TBL] [Abstract][Full Text] [Related]
33. A D53 repression motif induces oligomerization of TOPLESS corepressors and promotes assembly of a corepressor-nucleosome complex.
Ma H; Duan J; Ke J; He Y; Gu X; Xu TH; Yu H; Wang Y; Brunzelle JS; Jiang Y; Rothbart SB; Xu HE; Li J; Melcher K
Sci Adv; 2017 Jun; 3(6):e1601217. PubMed ID: 28630893
[TBL] [Abstract][Full Text] [Related]
34. Corepressor diversification by alternative mRNA splicing is species specific.
Privalsky ML; Snyder CA; Goodson ML
BMC Evol Biol; 2016 Oct; 16(1):221. PubMed ID: 27756201
[TBL] [Abstract][Full Text] [Related]
35. Structural basis for the assembly of the SMRT/NCoR core transcriptional repression machinery.
Oberoi J; Fairall L; Watson PJ; Yang JC; Czimmerer Z; Kampmann T; Goult BT; Greenwood JA; Gooch JT; Kallenberger BC; Nagy L; Neuhaus D; Schwabe JW
Nat Struct Mol Biol; 2011 Feb; 18(2):177-84. PubMed ID: 21240272
[TBL] [Abstract][Full Text] [Related]
36. Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity.
Stanley TB; Leesnitzer LM; Montana VG; Galardi CM; Lambert MH; Holt JA; Xu HE; Moore LB; Blanchard SG; Stimmel JB
Biochemistry; 2003 Aug; 42(31):9278-87. PubMed ID: 12899614
[TBL] [Abstract][Full Text] [Related]
37. NAC1 attenuates BCL6 negative autoregulation and functions as a BCL6 coactivator of FOXQ1 transcription in cancer cells.
Gao M; Herlinger AL; Wu R; Wang TL; Shih IM; Kong B; Rangel LBA; Yang JM
Aging (Albany NY); 2020 May; 12(10):9275-9291. PubMed ID: 32412910
[TBL] [Abstract][Full Text] [Related]
38. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor.
Trtková K; Pašková L; Matiješčuková N; Kolář Z
Cancer Biomark; 2010; 7(2):79-90. PubMed ID: 21178266
[TBL] [Abstract][Full Text] [Related]
39. Structure of the polycomb group protein PCGF1 in complex with BCOR reveals basis for binding selectivity of PCGF homologs.
Junco SE; Wang R; Gaipa JC; Taylor AB; Schirf V; Gearhart MD; Bardwell VJ; Demeler B; Hart PJ; Kim CA
Structure; 2013 Apr; 21(4):665-71. PubMed ID: 23523425
[TBL] [Abstract][Full Text] [Related]
40. The corepressors BCOR and BCORL1: two novel players in acute myeloid leukemia.
Tiacci E; Grossmann V; Martelli MP; Kohlmann A; Haferlach T; Falini B
Haematologica; 2012 Jan; 97(1):3-5. PubMed ID: 22210327
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
